Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy.

Anticancer research - 1 Jan 2015

Pasqualetti Francesco, Bocci Guido, Mey Valentina, Menghini Valentina, Montrone Sabrina, Cocuzza Paola, Ferrazza Patrizia, Seccia Veronica, Delishaj Durim, Orlandini Cinzia, Fabrini Maria Grazia, Danesi Romano

Abstract excerpt

BACKGROUND: Radiotherapy (RT) with or without chemotherapy (CT) plays an important role as exclusive treatment in patients with head and neck squamous cell cancer (HNSCC). Unfortunately, in some cases, benefit for patients is not recorded and only treatment-related complications are registered. MATERIALS AND METHODS: Data relating to Akt1 single nucleotide polymorphism (SNP) and response to treatment of 46...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Head and Neck Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Polymorphism, Single Nucleotide

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins c-akt

Share to Radiation Tolerance

Share to Squamous Cell Carcinoma of Head and Neck

Source

Identifiers

PMID: 25550560

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy.PMID 25550560Read ↗

PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.Semantic proximity Read ↗

EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapySemantic proximity Read ↗

Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.Semantic proximity Read ↗

Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.Semantic proximity Read ↗

Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population.Semantic proximity Read ↗

Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma.Semantic proximity Read ↗

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell CarcinomasSemantic proximity Read ↗

AKT1 polymorphisms and survival of early stage non-small cell lung cancer.Semantic proximity Read ↗

Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Characteristics of and Survival in Oral Squamous Cell Carcinomas in Norway (NOROC) 2005-2009Semantic proximity Read ↗

Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.